Antimicrobial resistance: The complex challenge of measurement to inform policy and the public

1. de Kraker MEA, Stewardson AJ, Harbarth S. Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? PLoS Med. 2016;13(11):e1002184. doi: 10.1371/journal.pmed.1002184 27898664

2. World Health Organization. Global action plan on antimicrobial resistance. Geneva: WHO 2015. Available from: http://www.who.int/iris/bitstream/10665/193736/1/9789241509763_eng.pdf?ua=1

3. United Nations. Political declaration of the high-level meeting of the General Assembly on antimicrobial resistance. New York: United Nations; 2016. Available from: http://www.un.org/pga/71/wp-content/uploads/sites/40/2016/09/DGACM_GAEAD_ESCAB-AMR-Draft-Political-Declaration-1616108E.pdf

4. Laxminarayan R, Chaudhury RR. Antibiotic Resistance in India: Drivers and Opportunities for Action. PLoS Med. 2016;13(3):e1001974. doi: 10.1371/journal.pmed.1001974 26934098

5. World Health Organization. Library of national action plans. Not dated. [cited 2017 10 July]. http://www.who.int/antimicrobial-resistance/national-action-plans/library/en/

6. Gelband H, Miller-Petrie M, Pant S, Gandra S, Levinson J, Barter D, et al. The State of the World's Antibiotics. Washington DC: The Center for Disease dynamics, Economics & Policy; 2015. Available from: https://cddep.org/sites/default/files/swa_2015_final.pdf

7. Ardal C, Outterson K, Hoffman SJ, Ghafur A, Sharland M, Ranganathan N, et al. International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet. 2016; 387(10015):296–307. doi: 10.1016/S0140-6736(15)00470-5 26603920.

8. World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Geneva: WHO; 2017. Available from: http://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf?ua=1

9. Laxminarayan R, Klugman KP. Communicating trends in resistance using a drug resistance index. BMJ Open. 2011;1(2):e000135. doi: 10.1136/bmjopen-2011-000135 22102636

10. Laxminarayan R, Sridhar D, Blaser M, Wang M, Woolhouse M. Achieving global targets for antimicrobial resistance. Science. 2016; 353(6302):874–5. doi: 10.1126/science.aaf9286 27540009

11. World Health Organization. Antimicrobial resistance: Global report on surveillance. Geneva: WHO; 2014. Available from: http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1

12. Koremenos B. The continent of international law: explaining agreement design. Cambridge, United Kingdom: Cambridge University Press; 2016.

13. Kelley JG, Simmons BA. Politics by number: Indicators as social pressure in international relations. Am J Polit Sci. 2015; 59(1):55–70. doi: 10.1111/ajps.12119

14. Lancet The. Why rank countries by health performance? Lancet. 2001; 357(9269):1633. doi: 10.1016/S0140-6736(00)04853-4 11425360

15. Gisselquist RM. Developing and evaluating governance indexes: 10 questions. Policy Studies. 2014; 35(5):513–31. doi: 10.1080/01442872.2014.946484

16. Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016; 387(10014):176–87. doi: 10.1016/S0140-6736(15)00473-0 26603922

17. Harbarth S, Samore MH. Antimicrobial resistance determinants and future control. Emerg Infect Dis. 2005; 11(6):794–801. Epub 2005/06/21. doi: 10.3201/eid1106.050167 15963271.

18. Folke C, Biggs R, Norström AV, Reyers B, Rockström J. Social-ecological resilience and biosphere-based sustainability science. Ecol Soc. 2016; 21(3):41. doi: 10.5751/ES-08748-210341

19. Tittensor DP, Walpole M, Hill SLL, Boyce DG, Britten GL, Burgess ND, et al. A mid-term analysis of progress toward international biodiversity targets. Science. 2014; 346(6206):241–4. doi: 10.1126/science.1257484 25278504

20. Donabedian A. The quality of care. How can it be assessed? JAMA. 1988; 260(12):1743–8. 3045356.

21. Burris SC, Wagenaar A, Swanson JW, Ibrahim JK, Wood J, Mello MM. Making the Case for Laws that Improve Health: A Framework for Public Health Law Research. Milbank Q. 2010; 88(2):169–210. doi: 10.1111/j.1468-0009.2010.00595.x 20579282

22. Van Boeckel TP, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci U S A. 2015;112(18):5649–54. doi: 10.1073/pnas.1503141112 25792457

23. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014; 14(8):742–50. doi: 10.1016/S1473-3099(14)70780-7 25022435.

24. Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis. 2011;11(9):692–701. doi: 10.1016/S1473-3099(11)70054-8 21659004

25. World Health Organization. Worldwide country situation analysis: response to antimicrobial resistance. Geneva: WHO; 2015. Available from: http://apps.who.int/iris/bitstream/10665/163468/1/9789241564946_eng.pdf?ua=1&ua=1

26. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. Atlanta: CDC; 2013. Available from https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf

27. World Health Organization. International health regulations (2005). Geneva: WHO; 2008. Available from http://apps.who.int/iris/bitstream/10665/246107/1/9789241580496-eng.pdf?ua=1

28. Global Health Security Agenda. Antimicrobial Resistance Action Package. Not dated. [cited 2017 18 March]. Available from: https://www.ghsagenda.org/packages/p1-antimicrobial-resistance.

29. World Health Organization. Drug-resistant TB: surveillance and response: supplement to global tuberculosis report. Geneva: WHO; 2014. Available from: http://www.who.int/tb/publications/global_report/gtbr14_supplement_web_v3.pdf

30. Freeman S, Okoroafor NO, Gast CM, Koval M, Nowowiejski D, O’Connor E, et al. Crowdsourced data indicate widespread multidrug resistance in skin flora of healthy young adults. J Microbiol Biol Educ. 2016; 17(1):172–82. doi: 10.1128/jmbe.v17i1.1008 27047615.

31. Jorgensen PS, Wernli D, Carroll SP, Dunn RR, Harbarth S, Levin SA, et al. Use antimicrobials wisely. Nature. 2016;537(7619):159–61. Epub 2016/09/09. doi: 10.1038/537159a 27604934.

32. Young OR. Governing complex systems: social capital for the anthropocene. Cambridge: The MIT Press; 2017.

33. Heymann DL, Chen L, Takemi K, Fidler DP, Tappero JW, Thomas MJ, et al. Global health security: the wider lessons from the west African Ebola virus disease epidemic. Lancet. 2015; 385(9980):1884–901. doi: 10.1016/S0140-6736(15)60858-3 25987157

34. Strategic Advisory Group of Experts on Immunization. Midterm review of the global vaccine action plan. Geneva: World Health Organization, 2016. Available from: http://www.who.int/immunization/sage/meetings/2016/october/1_Draft_GVAP_Assessment_report_2016_for_Yellow_Book_28_Sep_2016.pdf?ua=1

35. Mendelson M, Dar OA, Hoffman SJ, Laxminarayan R, Mpundu MM, Rottingen JA. A Global Antimicrobial Conservation Fund for Low- and Middle-Income Countries. Int J Infect Dis. 2016; 51:70–2. Epub 2016/09/21. doi: 10.1016/j.ijid.2016.09.016 27647658.

36. Gelband H. CARA: The Conscience of Antimicrobial Resistance Accountability, and the next big thing for CDDEP. 2016 [cited 2017 4 April]. Available from: http://www.cddep.org/blog/posts/cara_conscience_antimicrobial_resistance_accountability_and_next_big_thing_cddep#sthash.nSbsM5bO.dpuf.

37. Gemmill B, Bamidele-Izu A. The role of NGOs and civil society in global environmental governance. In: Esty DC, MH I, editors. Global environmental governance: Options and opportunities. Yale Center for Environmental Law & Policy; 2002.

38. United Nations Economic Commission for Europe. Convention on Access to Information, Public Participation in Decision-making and Access to Justice in Environmental Matters. Aarhus: UNECE; 1998. Available from: https://www.unece.org/fileadmin/DAM/env/pp/documents/cep43e.pdf.